Logistic regression models | Factors for treatment failure | Status | No. recipients with treatment failure/ total recipients | OR(95% CI) |
---|---|---|---|---|
Model Aa | Pre-transplant donor HBV DNA | Negative | 9/59 (15.3%) | 1 |
Positive | 9/24 (37.5%) | 6.73 (1.62,36.47) | ||
Recipient sex | Female | 1/19 (5.3%) | 1 | |
Male | 17/64 (26.6%) | 16.65 (2.07,397.13) | ||
Pre-transplant recipient HBcAb | Negative | 11/25 (44.0%) | 1 | |
Positive | 7/58 (12.1%) | 0.08 (0.02,0.31) | ||
Anti-viral prophylaxis | No | 4/18 (22.2%) | 1 | |
Yes | 14/65 (21.5%) | 0.66 (0.13,3.43) | ||
Model Bb | Pre-transplant donor HBV DNA | Negative | 9/59 (15.3%) | 1 |
Positive | 9/24 (37.5%) | 5.95 (1.55,29.39) | ||
Recipient sex | Female | 1/19 (5.3%) | 1 | |
Male | 17/64 (26.6%) | 17.10 (2.14,407.15) | ||
Pre-transplant recipient HBcAb | Negative | 11/25 (44.0%) | 1 | |
Positive | 7/58 (12.1%) | 0.08 (0.02,0.31) |